As per attachment
Awaiting price reaction for this filing.
The Board of Medinova Diagnostic Services Ltd approved the unaudited financial results for the quarter ended June 30, 2025. On a standalone basis, revenue from operations rose to Rs. 207.83 lakhs from Rs. 185.51 lakhs in Q1 FY25, while profit after tax more than doubled to Rs. 35.63 lakhs (vs Rs. 16.63 lakhs). On a consolidated basis, revenue grew to Rs. 272.13 lakhs (vs Rs. 249.05 lakhs) and PAT increased to Rs. 66.08 lakhs (vs Rs. 42.24 lakhs). Basic EPS stood at Rs. 0.36 (standalone) and Rs. 0.66 (consolidated). The statutory auditor M. Anandam & Co. issued an unmodified review report on both sets of results. The auditor also flagged an Emphasis of Matter noting the ongoing Scheme of Amalgamation of the company with its holding company Vijaya Diagnostic Centre Limited, which has received shareholder approval and is pending NCLT clearance.
Strong profit growth driven by margin expansion signals improved operational efficiency, which is positive for shareholders. However, the pending amalgamation with Vijaya Diagnostic Centre Limited remains the key event to watch, as its approval will determine the company's future listing status and shareholder structure.